148 related articles for article (PubMed ID: 15736963)
21. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
Maga G; Amacker M; Hübscher U; Gosselin G; Imbach JL; Mathé C; Faraj A; Sommadossi JP; Spadari S
Nucleic Acids Res; 1999 Feb; 27(4):972-8. PubMed ID: 9927728
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
24. The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
Selmi B; Deval J; Alvarez K; Boretto J; Sarfati S; Guerreiro C; Canard B
J Biol Chem; 2003 Oct; 278(42):40464-72. PubMed ID: 12902345
[TBL] [Abstract][Full Text] [Related]
25. Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs).
Goldschmidt V; Marquet R
Int J Biochem Cell Biol; 2004 Sep; 36(9):1687-705. PubMed ID: 15183338
[TBL] [Abstract][Full Text] [Related]
26. Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.
King RW; Klabe RM; Reid CD; Erickson-Viitanen SK
Antimicrob Agents Chemother; 2002 Jun; 46(6):1640-6. PubMed ID: 12019069
[TBL] [Abstract][Full Text] [Related]
27. Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.
Meyer PR; Matsuura SE; Schinazi RF; So AG; Scott WA
Antimicrob Agents Chemother; 2000 Dec; 44(12):3465-72. PubMed ID: 11083661
[TBL] [Abstract][Full Text] [Related]
28. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases.
Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP
Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397
[TBL] [Abstract][Full Text] [Related]
29. Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors.
Balzarini J; De Clercq E; Carbonez A; Burt V; Kleim JP
AIDS Res Hum Retroviruses; 2000 Apr; 16(6):517-28. PubMed ID: 10777142
[TBL] [Abstract][Full Text] [Related]
30. Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach.
Lee K; Chong Y; Chu CK
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):385-8. PubMed ID: 11563052
[TBL] [Abstract][Full Text] [Related]
31. Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations.
Basavapathruni A; Vingerhoets J; de Béthune MP; Chung R; Bailey CM; Kim J; Anderson KS
Biochemistry; 2006 Jun; 45(23):7334-40. PubMed ID: 16752922
[TBL] [Abstract][Full Text] [Related]
32. The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations.
Rodríguez-Barrios F; Balzarini J; Gago F
J Am Chem Soc; 2005 May; 127(20):7570-8. PubMed ID: 15898808
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 5'-triphosphate mimics (P3Ms) of 3'-azido-3',5'-dideoxythymidine and 3',5'-dideoxy-5'-difluoromethylenethymidine as HIV-1 reverse transcriptase inhibitors.
Rajwanshi VK; Prhavc M; Fagan P; Brooks JL; Hurd T; Cook PD; Wang G
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):179-89. PubMed ID: 15892257
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of AZT-resistant human immunodeficiency virus type 1 reverse transcriptase by casein kinase II in vitro: effects on inhibitor sensitivity.
Lazaro JB; Boretto J; Selmi B; Capony JP; Canard B
Biochem Biophys Res Commun; 2000 Aug; 275(1):26-32. PubMed ID: 10944435
[TBL] [Abstract][Full Text] [Related]
35. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070
[TBL] [Abstract][Full Text] [Related]
36. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
Larder BA; Kellam P; Kemp SD
Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
[TBL] [Abstract][Full Text] [Related]
37. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
Freeman GA; Andrews Iii CW; Hopkins AL; Lowell GS; Schaller LT; Cowan JR; Gonzales SS; Koszalka GW; Hazen RJ; Boone LR; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Reynolds DJ; Milton J; Ren J; Stuart DI; Stammers DK; Chan JH
J Med Chem; 2004 Nov; 47(24):5923-36. PubMed ID: 15537347
[TBL] [Abstract][Full Text] [Related]
38. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase.
Dharmasena S; Pongracz Z; Arnold E; Sarafianos SG; Parniak MA
Biochemistry; 2007 Jan; 46(3):828-36. PubMed ID: 17223704
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
Arion D; Kaushik N; McCormick S; Borkow G; Parniak MA
Biochemistry; 1998 Nov; 37(45):15908-17. PubMed ID: 9843396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]